Pharmacokinetics of pulmonary indacaterol in rat lung using molecular imprinting solid-phase extraction coupled with RP-UPLC
Open Access
- 4 October 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-16
Abstract
Indacaterol, a β2 agonist prescribed for long-term management of patients with chronic obstructive pulmonary disease and asthma. In this study the first MISPE cartridges was developed using indacaterol as a template for its selective extraction from rat lung tissues, enabling precise pharmacokinetic evaluation at the drug’s site of action. A molecular imprinting polymer was synthesized using indacaterol as a template, methacrylic acid as a functional monomer and ethylene glycol dimethacrylate as a cross-linker with a molar ratio (1: 4: 20). The polymer was characterized by a high binding capacity of 9840 ± 0.86 and high selectivity with an imprinting factor of 4.53 ± 0.12. The synthesized polymer was utilized as a sorbent in solid-phase extraction to purify and extract indacaterol from lung tissue matrix. The optimum molecularly imprinted solid-phase extraction (MISPE) conditions were 20.0 mg of molecular imprinting polymer and non-imprinting polymer, acetonitrile as the loading solvent, acetonitrile: water (20: 80; by volume) as the washing solvent, and methanol: acetic acid (90: 10; by volume) as the eluting solvent. A pharmacokinetic study was performed for indacaterol in rat lungs using the synthesized and optimized MISPE cartridge as a tool for sample purification. These parameters were determined in the lung tissues of rats emphasizing the local exposure of indacaterol to its target organ. The Cmax and Tmax were 51.020 ± 2.810 µg mL− 1 and 0.083 ± 0.001 h, respectively. The AUC 0−24 and AUC0 − inf were 175.920 ± 1.053 and 542.000 ± 5.245 µg h mL− 1, respectively. The elimination rate constant was 0.014 ± 0.00012 h− 1 and the half-life time was 48.510 ± 0.012 h. This study successfully developed and optimized MISPE cartridges using indacaterol as a template, enabling precise pharmacokinetic evaluation in rat lung tissues. The cartridges demonstrated high binding capacity and selectivity, providing crucial insights into the local exposure of indacaterol at its site of action.Keywords
Funding Information
- Cairo University
This publication has 40 references indexed in Scilit:
- A review of the modern principles and applications of solid-phase extraction techniques in chromatographic analysisAnalytical Sciences, 2022
- Synthesis of novel magnetic molecularly imprinted polymers by solid‐phase extraction method for removal of norfloxacinChinese Journal of Analytical Chemistry, 2022
- Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with AsthmaEuropean Journal of Drug Metabolism and Pharmacokinetics, 2021
- High‐throughput liquid chromatography tandem mass spectrometry assay as initial testing procedure for analysis of total urinary fractionDrug Testing and Analysis, 2020
- The micromechanics of lung alveoli: structure and function of surfactant and tissue componentsHistochemistry and Cell Biology, 2018
- Spectrophotometric and spectrofluorimetric determination of indacaterol maleate in pure form and pharmaceutical preparations: application to content uniformityLuminescence, 2015
- Molecularly Imprinted Polymers as Artificial Receptors2010
- Molecularly imprinted polymers and their application in solid phase extractionJournal of Separation Science, 2009
- Molecularly templated materials in chemical sensingAnalytica Chimica Acta, 2007
- Theoretical and experimental study of nicotinamide molecularly imprinted polymers with different porogensAnalytica Chimica Acta, 2005